Silencing of Diphthamide Synthesis 3 (Dph3) Reduces Metastasis of Murine Melanoma

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Wang, Lei ^a   Shi, Yu ^a   Ju, Peijun ^a   Liu, Rui ^b   Yeo, Siok Ping ^a   Xia, Yinyan ^a   Owlanj, Hamed ^a   Feng, Zhiwei ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHAMIDE SYNTHESIS 3; MESSENGER RNA; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DPH3 GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HETEROZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MELANOMA CELL; MELANOMA SKIN CANCER; METASTASIS; MOUSE; NONHUMAN; SKIN CARCINOGENESIS; TUMOR PROMOTION;

ANIMALS; CARRIER PROTEINS; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

MURINAE;

EID: 84869747261     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049988     Document Type: Article

References (47)

1. Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, et al. (2009) Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15(4): 294-303.
2. Miller AJ, Mihm MC Jr, (2006) Melanoma. N Engl J Med 355(1): 51-65.
3. Gray-Schopfer V, Wellbrock C, Marais R, (2007) Melanoma biology and new targeted therapy. Nature 445(7130): 851-857.
4. Vidwans SJ, Flaherty KT, Fisher DE, Tenenbaum JM, Travers MD, et al. (2011) A melanoma molecular disease model. PLoS ONE 6(3): e18257 doi:10.1371/journal.pone.0018257.
5. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, et al. (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88(23): 1731-1737.
6. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144(5): 646-674.
7. Dissanayake SK, Wade M, Johnson CK, O'Connell MP, Leotlela PD, et al. (2007) The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 282(23): 17259-17271.
8. Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K, (2005) The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Res 65(6): 2387-2396.
9. Ma L, Weinberg RA, (2008) Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 24(9): 448-456.
10. Stafford LJ, Vaidya KS, Welch DR, (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40(5): 874-891.
11. Kim SO, Ha SD, Lee S, Stanton S, Beutler B, et al. (2007) Mutagenesis by retroviral insertion in chemical mutagen-generated quasi-haploid mammalian cells. Biotechniques 42(4): 493-501.
12. Wang X, Ono K, Kim SO, Kravchenko V, Lin SC, et al. (2001) Metaxin is required for tumor necrosis factor-induced cell death. EMBO reports 2(7): 628-633.
13. Zarubin T, Jing Q, New L, Han J, (2005) Identification of eight genes that are potentially involved in tamoxifen sensitivity in breast cancer cells. Cell Res 15(6): 439-446.
14. Webb TR, Cross SH, McKie L, Edgar R, Vizor L, et al. (2008) Diphthamide modification of eEF2 requires a J-domain protein and is essential for normal development. J Cell Sci 121: 3140-3145.
15. Wu F, Zhang J, Sun J, Huang H, Ji P, et al. (2008) Solution structure of human DESR1, a CSL zinc-binding protein. Proteins 71(1): 514-518.
16. Liu S, Milne T, Kuremsky JG, Fink GR, Leppla SH, (2004) Identification of the proteins required for biosynthesis of diphthamide, the target of bacterial ADP-ribosylating toxins on translation elongation factor 2. Mol Cell Biol 24(21): 9487-9497.
17. Chen CM, Behringer RR, (2005) OVCA1: tumor suppressor gene. Curr Opin Genet Dev 15(1): 49-54.
18. Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A, et al. (1999) Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Cancer Res 59(19): 4973-4983.
19. Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong A, et al. (1996) Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 56(9): 1997-2002.
20. Chen CM, Behringer RR, (2004) Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Genes Dev 18(3): 320-332.
21. Liang M, Ayanga B, Du S, Godwin AK, Hartsock JK, et al. (2008) Ovca1, a candidate gene of the genetic modifier of Tp53, Mop2, affects mouse embryonic lethality. Gene Chromosomes Canc 47(4): 315-325.
22. Sjolinder M, Uhlmann J, Ponstingl H, (2002) DelGEF, a homologue of the Ran guanine nucleotide exchange factor RanGEF, binds to the exocyst component Sec5 and modulates secretion. FEBS letters 532(1-2): 211-215.
23. Sjolinder M, Uhlmann J, Ponstingl H, (2004) Characterisation of an evolutionary conserved protein interacting with the putative guanine nucleotide exchange factor DelGEF and modulating secretion. Exp Cell Res 294(1): 68-76.
24. Liu S, Wiggins JF, Sreenath T, Kulkarni AB, Ward JM, et al. (2006) Dph3, a small protein required for diphthamide biosynthesis, is essential in mouse development. Mol Cell Biol 26(10): 3835-3841.
25. Liu S, Leppla SH, (2003) Retroviral insertional mutagenesis identifies a small protein required for synthesis of diphthamide, the target of bacterial ADP-ribosylating toxins. Mol Cell 12(3): 603-613.
26. Fichtner L, Schaffrath R, (2002) KTI11 and KTI13, Saccharomyces cerevisiae genes controlling sensitivity to G1 arrest induced by Kluyveromyces lactis zymocin. Mol Microbiol 44(3): 865-875.
27. Fichtner L, Jablonowski D, Schierhorn A, Kitamoto HK, Stark MJR, et al. (2003) Elongator's toxin-target (TOT) function is nuclear localization sequence dependent and suppressed by post-translational modification. Mol Microbiol 49(5): 1297-1307.
28. Sato S, Fujita N, Tsuruo T, (2000) Modulation of Akt kinase activity by binding to Hsp90. P Natl Acad Sci of the USA 97(20): 10832-10837.
29. Shi Y, Liu R, Zhang S, Xia YY, Yang HJ, et al. (2011) Neural cell adhesion molecule potentiates invasion and metastasis of melanoma cells through CAMP-dependent protein kinase and phosphatidylinositol 3-kinase pathways. Int J Biochem Cell Biol 43(4): 682-690.
30. Poste G, Doll J, Brown AE, Tzeng J, Zeidman I, (1982) Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases. Cancer Res 42(7): 2770-2778.
31. Poste G, Doll J, Hart IR, Fidler IJ, (1980) In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res 40(5): 1636-1644.
32. Liotta LA, Stetler-Stevenson WG, (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s.
33. Kim D, Kim S, Koh H, Yoon SO, Chung AS, et al. (2001) Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB journal 15(11): 1953-1962.
34. Ugurel S, Utikal J, Becker JC, (2009) Tumor biomarkers in melanoma. Cancer control: journal of the Moffitt Cancer Center 16(3): 219-224.
35. Coussens LM, Fingleton B, Matrisian LM, (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295(5564): 2387-2392.
36. Seong I, Min HJ, Lee J-H, Yeo C-Y, Kang DM, et al. (2012) Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes. PLoS ONE 7(2): e31477 doi: 10.1371/journal.pone.0031477.
37. Jemal A, Devesa SS, Hartge P, Tucker MA, (2001) Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93(9): 678-683.
38. Giblin AV, Thomas JM, (2001) Incidence, mortality and survival in cutaneous melanoma. JPRAS 60(1): 32-40.
39. Ortiz PA, Ulloque R, Kihara GK, Zheng H, Kinzy TG, (2006) Translation elongation factor 2 anticodon mimicry domain mutants affect fidelity and diphtheria toxin resistance. J Biol Chem 281(43): 32639-32648.
40. Zhang Y, Zhu X, Torelli AT, Lee M, Dzikovski B, et al. (2010) Diphthamide biosynthesis requires an organic radical generated by an iron-sulphur enzyme. Nature 465(7300): 891-896.
41. Dhawan P, Singh AB, Ellis DL, Richmond A, (2002) Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res 62(24): 7335-7342.
42. Kim HJ, Kim YM, Lim S, Nam YK, Jeong J, et al. (2009) Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 28(1): 117-127.
43. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, et al. (2003) Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63(1): 196-206.
44. Bischoff FR, Ponstingl H, (1991) Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1. Nature 354(6348): 80-82.
45. Guo W, Tamanoi F, Novick P, (2001) Spatial regulation of the exocyst complex by Rho1 GTPase. Nat Cell Biol 3(4): 353-360.
46. Brymora A, Valova VA, Larsen MR, Roufogalis BD, Robinson PJ, (2001) The brain exocyst complex interacts with RalA in a GTP-dependent manner: identification of a novel mammalian Sec3 gene and a second Sec15 gene. J Biol Chem 276(32): 29792-29797.
47. Kumar V, Zhang MX, Swank MW, Kunz J, Wu GY, (2005) Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 25(49): 11288-11299.